CLEVELAND, May 23, 2018 /PRNewswire/ — Experts in MR image-guided radiation therapy will share their experiences during an educational symposium to be held on Friday, September 28, 2018 in Miami. The event aims to facilitate clinical and scientific discovery, as well as educate clinicians interested in the novel advancements of MR image-guided radiation therapy for treating cancer.
The symposium, titled “Adaptive MR Image-Guided Radiotherapy: Experience & Applications in Routine Clinical Practice,” will highlight various topics ranging from technical considerations such as linear accelerator system commissioning and quality assurance, to clinical information, such as clinical trials and protocols. Presenters will also discuss clinical experience and early outcomes data, with particular emphasis on the practice of on-table adaptive radiotherapy.
More than 10 clinicians will present their MR image-guided radiation therapy experience. Speakers include clinicians from top tier institutions including Miami Cancer Institute; Henry Ford Health System; Loyola UniversityMedical Center Chicago; NewYork-Presbyterian; Weill Cornell Medical Center; UF Health Cancer Center (Orlando Health); the University of Wisconsin; Carbone Cancer Center; Siteman Cancer Center at Washington University; and VU University Medical Center (VUmc).
The event will conclude with a tour of the MRIdian® Linac MR image-guided radiation therapy system at the symposium’s clinical host institution, Miami Cancer Institute at Baptist Health South Florida.
MR image-guided radiotherapy represents a major shift in the field of radiation oncology by using diagnostic-quality, high-definition anatomical image detail that’s unavailable with conventional image-guided radiotherapy (IGRT) technologies. By relying on the anatomical detail now visible with MR soft tissue imaging, clinicians are able to see changes to the tumor and surrounding tissues and quickly adjust for them each day while the patient is on the treatment table. Combined, MR imaging and the ability to adapt treatments dynamically provide clinicians with the tools capable of improving tumor targeting precision and thus allow for delivery of higher, and potentially more effective, radiation doses.
“We are excited to be a part of such an important educational event, featuring some of the foremost experts on MRI-guided radiation therapy and are thrilled to welcome attendees to our new state-of-the-art cancer center to tour our next generation MRIdian Linac system,” said Minesh Mehta, M.D., Deputy Director and Chief of Radiation Oncology at Miami Cancer Institute. “The Radiation Oncology community is recognizing the significant role MR-guidance can play in improving patient outcomes in radiation therapy, so meetings like these are vital in expanding patient access to this advanced form of therapy and evolving the ways in which it’s used in clinical practice.”
The symposium is sponsored by ViewRay, makers of MRIdian, the world’s first and only commercially available MR image-guided radiation therapy system. There is no fee to attend, but space is limited. To register, please visit https://ontable-adaptive-mr.eventbrite.com.